Login with ORCID

SENTENCE

Full identifier: http://www.w3.org/2000/01/rdf-schema#SENTENCE

References

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SENTENCE
Conclusions and Relevance Among patients with COVID-19 and moderate or severe ARDS, use of intravenous dexamethasone plus standard care compared with standard care alone resulted in a statistically significant increase in the number of ventilator-free days (days alive and free of mechanical ventilation) over the first 28 days.
Eva Zegelaar
2021-12-16T19:59:11.220Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SENTENCE
Conclusions and Relevance Among patients with COVID-19 and moderate or severe ARDS, use of intravenous dexamethasone plus standard care compared with standard care alone resulted in a statistically significant increase in the number of ventilator-free days (days alive and free of mechanical ventilation) over the first 28 days.
Eva Zegelaar
2021-12-16T19:59:09.305Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SENTENCE
Conclusions and Relevance Among patients with COVID-19 and moderate or severe ARDS, use of intravenous dexamethasone plus standard care compared with standard care alone resulted in a statistically significant increase in the number of ventilator-free days (days alive and free of mechanical ventilation) over the first 28 days.
Eva Zegelaar
2021-12-16T19:59:07.616Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SENTENCE
Conclusions and Relevance Among patients with COVID-19 and moderate or severe ARDS, use of intravenous dexamethasone plus standard care compared with standard care alone resulted in a statistically significant increase in the number of ventilator-free days (days alive and free of mechanical ventilation) over the first 28 days.
Eva Zegelaar
2021-12-16T19:59:05.405Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SENTENCE
Conclusions and Relevance Among patients with COVID-19 and moderate or severe ARDS, use of intravenous dexamethasone plus standard care compared with standard care alone resulted in a statistically significant increase in the number of ventilator-free days (days alive and free of mechanical ventilation) over the first 28 days.
Eva Zegelaar
2021-12-16T19:59:03.853Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SENTENCE
Conclusions and Relevance Among patients with COVID-19 and moderate or severe ARDS, use of intravenous dexamethasone plus standard care compared with standard care alone resulted in a statistically significant increase in the number of ventilator-free days (days alive and free of mechanical ventilation) over the first 28 days.
Eva Zegelaar
2021-12-16T19:59:01.706Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SENTENCE
Conclusions and Relevance Among patients with COVID-19 and moderate or severe ARDS, use of intravenous dexamethasone plus standard care compared with standard care alone resulted in a statistically significant increase in the number of ventilator-free days (days alive and free of mechanical ventilation) over the first 28 days.
Eva Zegelaar
2021-12-16T19:59:00.024Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SENTENCE
Conclusions and Relevance Among patients with COVID-19 and moderate or severe ARDS, use of intravenous dexamethasone plus standard care compared with standard care alone resulted in a statistically significant increase in the number of ventilator-free days (days alive and free of mechanical ventilation) over the first 28 days.
Eva Zegelaar
2021-12-16T19:58:58.096Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SENTENCE
Conclusions and Relevance Among patients with COVID-19 and moderate or severe ARDS, use of intravenous dexamethasone plus standard care compared with standard care alone resulted in a statistically significant increase in the number of ventilator-free days (days alive and free of mechanical ventilation) over the first 28 days.
Eva Zegelaar
2021-12-16T19:58:56.051Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SENTENCE
Conclusions and Relevance Among patients with COVID-19 and moderate or severe ARDS, use of intravenous dexamethasone plus standard care compared with standard care alone resulted in a statistically significant increase in the number of ventilator-free days (days alive and free of mechanical ventilation) over the first 28 days.
Eva Zegelaar
2021-12-16T19:58:54.680Z